Antitumor activities of metal oxide nanoparticles

Nanomaterials

Volumn 5, Issue 2, 2015, Pages 1004-1021

  Vinardell, Maria Pilar ^a   Mitjans, Montserrat ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Antitumor; Cancer therapy; In vitro; In vivo; Metal oxide nanoparticles

Indexed keywords

EID: 84937573167     PISSN: None     EISSN: 20794991     Source Type: Journal    
DOI: 10.3390/nano5021004     Document Type: Review

References (62)

1. Stewart, B.; Wild, C.P. World Cancer Report 2014; ISBN 978-92-832-0429-9; International Agency for Research on Cancer World Health Organization: Lyon, France, 2014. Available online: http://www.iarc.fr/en/publications/books/wcr/wcr-order.php (accessed on 24 March 2015).
2. Rasmussen, J.W.; Martinez, E.; Louka, P.; Wingett, D.G. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Exp. Opin. Drug Deliv. 2010, 7, 1063-1077.
3. Felice, B.; Prabhakaran, M.P.; Rodríguez, A.P.; Ramakrishna, S. Drug delivery vehicles on a nano-engineering perspective. Mater. Sci. Eng. C 2014, 41, 178-195.
4. Fernandes, E.; Ferreira, J.A.; Peixoto, A.; Lima, L.; Barroso, S.; Sarmento, B.; Santos, L.L. New trends in guided nanotherapies for digestive cancers: A systemic review. J. Control Release 2015, 209, 288-307.
5. Caputo, F.; de Nicola, M.; Ghibelli L. Pharmacological potential of bioactive engineered nanomaterials. Biochem. Pharmacol. 2014, 92, 112-130.
6. Danhier, F.; Feron, O.; Preat, V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control Release 2010, 148, 135-146.
7. Laurent, S.; Dutz, S.; Häfeli, U.O.; Mahmoudi, M. Magnetic fluid hyperthermia: Focus on superparamagnetic iron oxide nanoparticles. Adv. Colloid Interface Sci. 2011, 166, 8-23.
8. Orel, V.; Shevchenko, A.; Romanov, A.; Tselepi, M.; Mitrelias, T.; Barnes, C.H.; Burlaka, A.; Lukin, S.; Shchepotin, I. Magnetic properties and antitumor effect of anocomplexes of iron oxide and doxorubicin. Nanomedicine 2015, 11, 47-55.
9. Van Landeghem, F.K.; Maier-Hauff, K.; Jordan, A.; Hoffmann, K.-T.; Gneveckow, U.; Scholz, R.; Thiesen, B.; Brück, W.; von Deimling, A. Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 2009, 30, 52-57.
10. Silva, A.C.; Oliveira, T.R.; Mamani, J.B.; Malheiros, S.M.; Malavolta, L.; Pavon, L.F.; Sibov, T.T.; Amaro, E., Jr.; Tannus, A.; Vidoto, E.L. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int. J. Nanomed. 2011, 6, 591-603.
11. Johannsen, M.; Thiesen, B.; Wust, P.; Jordan, A. Magnetic nanoparticle hyperthermia for prostate cancer. Int. J. Hyperthermia 2010, 26, 790-795.
12. Maier-Hauff, K.; Ulrich, F.; Nestler, D.; Niehoff, H.; Wust, P.; Thiesen, B.; Orawa, H.; Budach, V.; Jordan, A. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J. Neurooncol. 2011, 103, 317-324.
13. Kolosnjaj-Tabi, J.; di Corato, R.; Lartigue, L.; Marango, I.; Guardia, P.; Silva, A.K., Luciani, N.; Clément, O.; Flaud, P.; Singh, J.V.; et al. Heat-generating iron oxide nanocubes: Subtle "destructurators" of the tumoral microenvironment. ACS Nano 2014, 8, 4268-4283.
14. Bhattacharyya, S.; Kudgus, R.A.; Bhattacharya, R.; Mukherjee, P. Inorganic nanoparticles in cancer therapy. Pharm Res. 2011, 28, 237-259.
15. Hilger, I.; Kaiser, W.A. Iron oxide-based nanostructures for MRI and magnetic hyperthermia. Nanomedicine 2012, 7, 1443-1459.
16. Bañobre-López, M.; Teijeiro, A.; Rivas, J. Magnetic nanoparticle-based hyper-thermia for cancer treatment. Rep. Pract. Oncol. Radiother. 2013, 18, 397-400.
17. Klein, S.; Sommer, A.; Distel, L.V.; Hazemann, J.L.; Kröner, W.; Neuhuber, W.; Müller, P.; Proux, O.; Kryschi, C. Superparamagnetic iron oxide nanoparticles as novel X-ray enhancer for low-dose radiation therapy. J. Phys. Chem. B 2014, 118, 6159-6166.
18. Chatterjee, D.K.; Fong, L.S.; Zhang, Y. Nanoparticles in photodynamic therapy: An emerging paradigm. Adv. Drug Deliv. Rev. 2008, 60, 1627-1637.
19. Zhang, A.P.; Sun, Y.P. Photocatalytic killing effect of TiO2 nanoparticles on Ls- 174-t human colon carcinoma cells. World J. Gastroenterol. 2004, 10, 3191-3193.
20. Thevenot, P.; Cho, J.; Wavhal, D.; Timmons, R.B.; Tang, L. Surface chemistry influences cancer killing effect of TiO2 nanoparticles. Nanomedicine 2008, 4, 226-236.
21. Seo, J.W.; Chung, H.; Kim, M.Y.; Lee, J.; Choi, I.H.; Cheon, J. Development of watersoluble single-crystalline TiO2 nanoparticles for photocatalytic cancer-cell treatment. Small 2007, 3, 850-853.
22. Cui, S.; Yin, D.; Chen, Y.; Di, Y.; Chen, H.; Ma, Y.; Achilefu, S.; Gu, Y. In vivo targeted deep-tissue photodynamic therapy based on near-infrared light triggered upconversion nanoconstruct. ACS Nano 2013, 7, 676-688.
23. Hou Z.; Zhang, Y.; Deng, K.; Chen, Y.; Li, X.;, Deng, X.; Cheng, Z.; Lian, H.; Li, C.; Lin, J. UV-emitting upconversion-based TiO2 photosensitizing nanoplatform: Near-infrared light mediated in vivo photodynamic therapy via mitochondria-involved apoptosis pathway. ACS Nano 2015, 9, 2584-2599.
24. Idris, N.M.; Lucky, S.S.; Li, Z.; Huang, K.; Zhang, Y. Photoactivation of core-shell titania coated upconversion nanoparticles and their effect on cell death. J. Mater. Chem. B 2014, 2, 7017-7026.
25. Lucky, S.S.; Idris, N.M.; Li, Z.; Huang, K.; Soo, K.C.; Zhang, Y. Titania coated upconversion nanoparticles for near-infrared light triggered photodynamic therapy. ACS Nano 2015, 9, 191-205.
26. Wason, M.S.; Colon, J.; Das, S.; Seal, S.; Turkson, J.; Zhao, J.; Baker, C.H. Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production. Nanomedicine 2013, 9, 558-569.
27. Colon, J.; Hsieh, N.; Ferguson, A.; Kupelian, P.; Seal, S.; Jenkins, D.W.; Baker, C.H. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine 2010, 6, 698-705.
28. Tarnuzzer, R.W.; Colon, J.; Patil, S.; Seal, S. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett. 2005, 5, 2573-2577.
29. Neri, D.; Supuran, C.T. Interfering with pH regulation in tumors as a therapeutic strategy. Nat. Rev. Drug Discov. 2011, 10, 767-777.
30. Ali, D.; Alarifi, S.; Alkahtani, S.; AlKahtane, A.A.; Almalik, A. Cerium oxide nanoparticles induce oxidative stress and genotoxicity in human skin melanoma cells. Cell Biochem. Biophys. 2014, 71, 1643-1651.
31. Pešić, M.; Podolski-Renić, A.; Stojković, S.; Matović, B.; Zmejkoski, D.; Kojić, V.; Bogdanović, G.; Pavićević, A.; Mojović, M.; Savić, A.; et al. Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity. Chem. Biol. Interact. 2015, 232, 85-93.
32. Sack, M.; Alili, L.; Karaman, E.; Das, S.; Gupta, A.; Seal, S.; Brenneisen. P. Combination of conventional chemotherapeutics with redox-active cerium oxide nanoparticles-A novel aspect in cancer therapy. Mol. Cancer Ther. 2014, 13, 1740-1749.
33. Alili, L.; Sack, M.; Karakoti, A.S.; Teuber, S.; Puschmann, K.; Hirst, S.M.; Reilly, C.M.; Zanger, K.; Stahl, W.; Das, S.; et al. Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions. Biomaterials 2011, 32, 2918-2929.
34. De Marzi, L.; Monaco, A.; de Lapuente, J.; Ramos, D.; Borras, M.; di Gioacchino, M.; Santucci, S.;, Poma, A.Cytotoxicity and genotoxicity of ceria nanoparticles on different cell lines in vitro. Int. J. Mol. Sci. 2013, 14, 3065-3077.
35. Alili, L.; Sack, M.; von Montfort, C.; Giri, S.; Das, S.; Carroll, K.S.; Zanger, K.; Seal, S.; Brenneisen, P. Downregulation of tumor growth and invasion by redox-active nanoparticles. Antioxid. Redox. Signal 2013, 19, 765-778.
36. Wahab, R.; Dwivedi, S.; Umar, A.; Singh, S.; Hwang, I.H.; Shin, H.S.; Musarrat, J.; Al-Khedhairy, A.A.; Kim, Y.S. ZnO nanoparticles induce oxidative stress in Cloudman S91 melanoma cancer cells. J. Biomed. Nanotechnol. 2013, 9, 441-449.
37. Wahab, R.; Kaushik, N.K.; Kaushik, N.; Choi, E.H.; Umar, A.; Dwivedi, S.; Musarrat, J.; Al-Khedhairy, A.A. ZnO nanoparticles induces cell death in malignant human T98G gliomas, KB and non-malignant HEK cells. J. Biomed. Nanotechnol. 2013, 9, 1181-1189.
38. Wahab, R.; Siddiqui, M.A.; Saquib, Q.; Dwivedi, S.; Ahmad, J.; Musarrat, J.; Al-Khedhairy, A.A.; Shin, H.S. ZnO nanoparticles induced oxidative stress and apoptosis in HepG2 and MCF-7 cancer cells and their antibacterial activity. Colloids Surf. B 2014, 117, 267-276.
39. Fang, R.H.; Hu, C.M.; Luk, B.T.; Gao, W.; Copp, J.A.; Tai, Y.; O'Connor, D.E.; Zhang, L. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 2014, 14, 2181-2188.
40. Bae, M.Y.; Cho, N.H.; Seong, S.Y. Protective anti-tumour immune responses by murine dendritic cells pulsed with recombinant T at carcinoembryonic antigen derived from Escherichia coli. Clin. Exp. Immunol. 2009, 157, 128-138.
41. Cho, N.H.; Cheong, T.C.; Min, J.H.; Wu, J.H.; Lee, S.J.; Kim, D.; Yang, J.S.; Kim, S.; Kim, Y.K.; Seong, S.Y. A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. Nat. Nanotechnol. 2011, 6, 675-682.
42. Yun, J.W.; Yoon, J.H.; Kang, B.C.; Cho, N.H.; Seok, S.H.; Min, S.K.; Min, J.H.; Che, J.H.; Kim, Y.K. The toxicity and distribution of iron oxide-zinc oxide core-shell nanoparticles in C57BL/6 mice after repeated subcutaneous administration. J. Appl. Toxicol. 2015, 35, 593-602.
43. Ryter, S.W.; Kim, H.P.; Hoetzel, A.; Park, J.W.; Nakahira, K.; Wang, X.; Choi, A.M. Mechanisms of cell death in oxidative stress. Antioxid. Redox. Signal 2007, 9, 49-89.
44. Baskar, G.; Chandhuru, J.; Sheraz Fahad, K.; Praveen, A.S.; Chamundeeswari, M.; Muthukumar, T. Anticancer activity of fungal L-asparaginase conjugated with zinc oxide nanoparticles. J. Mater. Sci. Mater. Med. 2015, 26, doi:10.1007/s10856-015-5380-z.
45. Hackenberg, S.; Scherzed, A.; Kessler, M.; Froelich, K.; Ginzkey, C.; Koehler, C.; Burghartz, M.; Hagen, R.; Kleinsasser, N. Zinc oxide nanoparticles induce photocatalytic cell death in human head and neck squamous cell carcinoma cell lines in vitro. Int. J. Oncol. 2010, 37, 1583-1590.
46. Hackenberg, S.; Scherzed, A.; Harnisch, W.; Froelich, K.; Ginzkey, C.; Koehler, C.; Hagen, R.; Kleinsasser, N. Antitumor activity of photo-stimulated zinc oxide nanoparticles combined with paclitaxel or cisplatin in HNSCC cell lines. J. Photochem. Photobiol. B 2012, 114, 87-93.
47. Guo, D.; Wu, C.; Jiang, H.; Li, Q.; Wang, X.; Chen, B. Synergistic cytotoxic effect of different sized ZnO nanoparticles and daunorubicin against leukemia cancer cells under UV irradiation. J. Photochem. Photobiol. B 2008, 93, 119-126.
48. Sankar, R.; Maheswari, R.; Karthik, S.; Shivashangari, K.S.; Ravikumar, V. Anticancer activity of Ficus religiosa engineered copper oxide nanoparticles. Mater. Sci. Eng. C 2014, 44, 234-239.
49. Sivaraj, R.; Rahman, P.K.; Rajiv, P.; Narendhran, S.; Venckatesh R. Biosynthesis and characterization of Acalypha indica mediated copper oxide nanoparticles and evaluation of its antimicrobial and anticancer activity. Spectrochim. Acta A 2014, 129, 255-258.
50. Narayanan, K.B., Sakthivel, N. Biological synthesis of metal nanoparticles by microbes. Adv. Colloid Interface Sci. 2010, 156, 1-13.
51. Zhang, X.; Wang, G.; Liu, X.; Wu, J.; Li, M.; Gu, J.; Liu, L.; Fang, B. Different CuO nanostructures: Synthesis, caracterization, and applications for glucose sensors. J. Phys. Chem. C 2008, 112, 16845-16849.
52. Cioffi, N.; Torsi, L.; Ditaranto, N.; Tantillo, G.; Ghibelli, L.; Sabbatini, L.; Bleve-Zacheo, T.; D'Alessio, M.; Zambonin, P.G.; Traversa, E. Copper nanoparticle/polymer composites with antifungal and bacteriostatic properties. Chem. Mater. 2005, 17, 5255-5262.
53. Wang, Y.; Zi, X.Y.; Su, J.; Zhang, H.X.; Zhang, X.R.; Zhu, H.Y.; Li, J.X.; Yin, M.; Yang, F.; Hu, Y.P. Cuprous oxide nanoparticles selectively induce apoptosis of tumor cells. Int. J. Nanomed. 2012, 7, 2641-2652.
54. Wang, Y.; Yang, F.; Zhang, H.-X.; Zi, X.Y.; Pan, X.H.; Chem, F.; Luo, W.D.; Li, J.X.; Zhu, H.Y.; Hu, Y.P. Cuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondria. Cell Death Dis. 2013, 4, doi:10.1038/cddis.2013.314.
55. Siddiqui, M.A.; Alhadlaq, H.A.; Ahmad, J.; Al-Khedhairy, A.A.; Musarrat, J.; Ahamed, M. Copper oxide nanoparticles induced mitochondria mediated apoptosis in human hepatocarcinoma cells. PLoS ONE 2013, 8, doi:0.1371/journal.pone.0069534.
56. Meng, H.; Wang, M.; Liu, H.; Liu, X.; Situ, A.; Wu, B.; Ji, Z.; Chang, C.H.; Nel, A.E. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice. ACS Nano 2015, 9, 3540-3557.
57. Lu,J.; Liong, M.; Li, Z.; Zink, J.I.; Tamanoi, F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010, 6, 1794-1805.
58. Bagwe, R.P.; Hilliard, L.R.; Tan W. Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. Langmuir 2006, 22, 4357-4362.
59. Botella, P.; Abasolo, I.; Fernández, Y.; Muniesa, C.; Miranda, S.; Quesada, M.; Ruiz, J.; Schwartz, S.; Corma, A. Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation. J. Control Release 2011, 156, 246-257.
60. Drummond, D.C.; Meyer, O.; Hong, K.; Kirpotin, D.B.; Papahadjopoulos, D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 1999, 51, 691-743.
61. Limbach, L.K.; Li, Y.; Grass, R.N.; Brunner, T.J.; Hintermann, M.A.; Muller, M.; Gunther, D.; Stark, W.J. Oxide nanoparticle uptake in human lung fibroblasts: Effects of particle size, agglomeration, and diffusion at low concentrations. Environ. Sci. Technol. 2005, 39, 9370-9376.
62. Lee, Y.K.; Choi, E.J.; Webster, T.J.; Kim, S.H.; Khang D. Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity. Int. J. Nanomed. 2014, 10, 97-113.